Marginal Zone Lymphoma | Topics

 
FDA Grants Priority Review to Zanubrutinib as Therapy for Pretreated Marginal Zone Lymphoma
May 19, 2021

Based on phase 1 and 2 trial results and pooled safety data from several clinical trials, zanubrutinib moves forward with a priority review in relapsed/refractory marginal zone lymphoma.

FDA Approves Umbralisib for Patients with Previously Treated MZL & FL
February 05, 2021

The approval of umbralisib was primarily based on data from the marginal zone lymphoma and follicular lymphoma patient cohorts of the phase 2b UNITY-NHL trial.

Progressive Red-to-Violaceous Papules and Plaques on the Neck and Abdominal Skin of a 70-Year-Old Woman
June 19, 2019

A 70-year-old woman developed red-to-violaceous papules, plaques, and nodule- like skin lesions several months prior to her presentation. The skin lesions mostly involved her lower neck and abdominal area. What is the most likely diagnosis?